Parisi Gray Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-970
Closed -$67K 290
2021
Q2
$67K Buy
+970
New +$64.8K 0.02% 268
2019
Q2
Sell
-1,135
Closed -$74K 232
2019
Q1
$74K Sell
1,135
-79
-7% -$5.25K 0.05% 165
2018
Q4
$75K Buy
1,214
+79
+7% +$5.52K 0.05% 149
2018
Q3
$87K Hold
1,135
0.05% 153
2018
Q2
$85K Sell
1,135
-35
-3% -$2.47K 0.06% 156
2018
Q1
$86K Hold
1,170
0.07% 148
2017
Q4
$87K Buy
+1,170
New +$88.8K 0.06% 150

Other funds holding GILD

Parisi Gray Wealth Management's GILD Position: Q3 2021 in Review

Parisi Gray Wealth Management sold out of Gilead Sciences (GILD) in Q3 2021, closing a stake of 970 shares — an estimated $67K sold.

Parisi Gray Wealth Management first reported a position in GILD in Q4 2017 and held it in 7 quarters. The position peaked at $87K in Q3 2018. 1,563 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

  • Parisi Gray Wealth Management reported no remaining Gilead Sciences position as of Q3 2021 after selling out during the quarter.
  • Parisi Gray Wealth Management sold 970 Gilead Sciences shares in Q3 2021, an estimated $67K.
  • Parisi Gray Wealth Management first reported a position in Gilead Sciences in Q4 2017 and held it in 7 quarters.
  • Parisi Gray Wealth Management's Gilead Sciences position peaked at $87K in Q3 2018.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Parisi Gray Wealth Management's 13F filing for Q3 2021, filed 16 Nov 2021.